Skip to Content

PAD 0115 (Flavoxate 100 mg)

Pill with imprint PAD 0115 is White, Round and has been identified as Flavoxate hydrochloride 100 mg. It is supplied by Paddock Laboratories, Inc..

Flavoxate is used in the treatment of dysuria; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Flavoxate 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for PAD 0115

Flavoxate hydrochloride

PAD 0115
100 mg
11.00 mm
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Paddock Laboratories, Inc.
Inactive Ingredients:
silicon dioxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
lactose monohydrate
magnesium stearate
methyl methacrylate
microcrystalline cellulose
sodium starch glycolate type A potato
hypromellose 2910 (6 mPa.s)
polyethylene glycol
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.